Navigation Links
Anti-tissue transglutaminase IgA Assay

ProductsAnti-tissue transglutaminase IgA Assay
Company Bio-Rad Laboratories
Item Anti-tissue transglutaminase IgA Assay
Features 
Description Tissue transglutaminase (tTg) is a ubiquitous enzyme that catalyzes the cross-linking of proteins. Tissue transglutaminase is also the specific protein that is identified by the endomysial antibody immunofluorescence (EMA) tests (Bio-Rad catalog number 29003 and 29060). Anti-tTg IgA and IgG serologic tests are highly sensitive and specific for celiac disease diagnosis.

Bio-Rad anti-tTG assays are used for the semi-quantitative and qualitative determination of IgA or IgG antibodies to tissue transglutaminase (tTG) in human serum.

Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. Anti-tissue transglutaminase IgG Assay
2. Uric Acid Enzymatic Assay
3. Lithium Enzymatic Assay Kit
4. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
5. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
6. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
7. Procleix HIV-1/HCV Assay
8. VERSANT HIV RNA 3.0 Assay (bDNA)
9. Wampole PreVue B. Burgdorferi Antibody Detection Assay
10. VerifyNow Aspirin Assay
11. VerifyNow IIb/IIIa Assay
Disposable Microscissors: Horizontal, Straight...
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
... original and very popular 1286 ... cutting in the vertical plane ... tips allow greater versatility when ... Tip is shaped like pic ...
Claes Shielded Retinotomy Scissors, Curved Vertical...
Medicine Products:
(Date:8/27/2014)... York, New York (PRWEB) August 27, 2014 ... be filed in U.S. courts on behalf of women ... to uterine morcellation, Bernstein Liebhard LLP reports. According to ... filed on August 18th in the U.S. District Court, ... hysterectomy patient who claims the use of a power ...
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
(Date:8/27/2014)... Amy Norton HealthDay Reporter ... who take part in clinical trials of new heart disease ... patient, a new study confirms. Experts said the findings, ... American Medical Association , aren,t surprising -- but they are ... enrolling a more select patient population that is not fully ...
(Date:8/27/2014)... spending for commercially insured individuals is due primarily to ... use, according to a new study led by researchers ... Practice, published in the August issue of the ... increasing concern that consolidation in the health care marketplace ... ultimately, consumers," said Carrie Colla, PhD, assistant professor at ...
(Date:8/27/2014)... Scientists at The Scripps Research Institute (TSRI) have ... can be associated with alcohol dependence. , This ... type 1 (Nf1), which TSRI scientists found is linked ... Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter that lowers ... novel and seminal study provides insights into the cellular ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:Tracking spending among the commercially insured 2Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2
... treated with genetically modified T cells remain healthy up to ... of Medicine at the University of Pennsylvania report in the ... provide a framework for the use of this type of ... HIV, cancer, and a wide variety of other diseases. ...
... researchers have succeeded in developing a biosynthetic polyphenol that ... The findings, published in a recent issue of the ... the feasibility of biosynthetic polyphenols as a possible therapy ... which there is currently no cure. Polyphenols, which ...
... WEDNESDAY, May 2 (HealthDay News) -- Chemistry in three ... a new, small study says. Along with providing ... could prove important in finding ways to treat depression, ... linked with decreased motivation, Vanderbilt University researchers said. ...
... past decade, there has been a steady stream of ... According to Dr. Louise Moist, a Scientist at Lawson ... for kidney patients undergoing hemodialysis. Hemodialysis can ... to join an artery to a vein. Unfortunately, AV ...
... , Houston, TX - Accelerated partial breast irradiation ... growing increasingly popular as a treatment choice for ... higher rate of later mastectomy, increased radiation-related toxicities ... irradiation (WBI), according to researchers from The University ...
... depression among patients with hepatitis C, but a standard ... can cause depression. In a review article, researchers ... and after initiating treatment with interferon. Dr. Murali ... co-author of the study, published in the International ...
Cached Medicine News:Health News:Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients 2Health News:Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients 3Health News:Biosynthetic grape-derived compound prevents progression of Alzheimer's disease in mice 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2Health News:Everyday fish oil capsule may provide kidney-related benefits 2Health News:APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation 2Health News:APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation 3Health News:Hepatitis C drug can cause depression 2
(Date:8/27/2014)... REDWOOD CITY, Calif. , Aug. 27, 2014 ... in emergency response system design, blended emergency medical ... for CPR/AED (automated external defibrillator) training from the ... and the Army Reserve 81 st ... Homeland Security and Investigations contract includes nationwide CPR/AED/First ...
(Date:8/27/2014)... WARSAW, Ind. , Aug. 27, 2014  Zimmer ... in musculoskeletal care, announced that it will be participating ... the Grand Hyatt in New York, New ... David Dvorak , President and CEO of Zimmer, will ... Binder , President and CEO of Biomet, will join ...
(Date:8/27/2014)... Aug. 27, 2014 Asterias Biotherapeutics Inc. (OTCBB: ... Drug Administration (FDA) to initiate a Phase 1/2a clinical ... cervical spinal cord injury.  The approved trial follows the ... the product, and is designed to assess safety and ... complete cervical spinal cord injuries, the first targeted indication ...
Breaking Medicine Technology:Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5